The U.S. health insurance industry relies heavily on private markets, but these markets are highly concentrated and are growing more so over time. In a new analysis, researchers document concentration ...

FDA’s NAM framework emphasizes context of use, human biological relevance, technical characterization, and fit-for-purpose ...

The Goldman Sachs Large Cap Value Fund underperformed in Q4 2025 despite gains from Alphabet and Caterpillar. Read the full ...

Please tell us about Rosenblatt’s trading desk. How is it structured and what makes it unique? Since our founding 46 years ...

Professor Gordon Cook says careful patient selection is needed with CAR-T cell therapy, noting its potential in a disease ...

To pay almost a million dollars to an unsuccessful job candidate can't help but raise questions about the successful candidate, writes Randy Evans.

Thank you, Dan. Good afternoon, everyone, and thank you for joining us today for Titan America's Fourth Quarter and Full Year ...

We explore critical stages of M&A transactions and examine how AI is now available for deployment at each stage and the ...

Dr. Brian S. Henick, a medical oncologist at Columbia University Irving Medical Center and director of the phase 1 program and translational research in aerodigestive cancers, outlined in an interview ...

Two former FBI agents have filed a lawsuit alleging that they were fired solely because they were assigned to investigate ...

Calamos CPZ reported a Q4 total return of -2.05% on NAV as the fund shifted exposure from AI beneficiaries to pro-growth cyclicals. Read the full analysis now.

In the U.S., states are rapidly pursuing all sorts of new AI laws. A new analysis usefully looked at them. I recap the ...